Literature DB >> 7393340

[3H]-Spiroperidol labels dopamine receptors in membranes from rabbit mesenteric artery.

O E Brodde, G Gross.   

Abstract

The potent dopamine receptor antagonist [3H]-spiroperidol was used to label binding sites in a membrane fraction derived from rabbit mesenteric artery which had characteristics expected for dopamine receptors. The binding was of high affinity with an equilibrium dissociation constant (KD) of 13.1 nM; it was saturable with 110 fmol of [3H]-spiroperidol bound/mg protein at maximal occupancy of the sites. Binding at 37 degrees C was rapid and readily reversible with rate constants of 0.0154nM-1 min-1 and 0.114min-1 for forward and reverse reaction, respectively. Dopamine receptor antagonists were about 100--200 times more potent than alpha-adrenolytic drugs in competing for the [3H]-spiroperidol binding sites and dopamine was much more potent than (-)-noradrenaline, (-)-isoprenaline, clonidine or serotonin. It is concluded that in a membrane fraction of the rabbit mesenteric artery there exist binding sites for [eH]-spiroperidol indistinguishable from dopamine receptors. Thus the present results support the view that in vascular smooth muscle there exist specific dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7393340     DOI: 10.1007/bf00569404

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  19 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Peripheral cardiovascular dopamine receptors.

Authors:  R G Pendleton; P E Setler
Journal:  Gen Pharmacol       Date:  1977

3.  Two binding sites for 3H-spiroperidol on rat striatal membranes.

Authors:  M Briley; S Z Langer
Journal:  Eur J Pharmacol       Date:  1978-08-01       Impact factor: 4.432

Review 4.  A comparison of the vascular dopamine receptor with other dopamine receptors.

Authors:  L I Goldberg; P H Volkman; J D Kohli
Journal:  Annu Rev Pharmacol Toxicol       Date:  1978       Impact factor: 13.820

5.  Dopamine receptors in bovine retina : characterization of the 3H-spiroperidol binding and its use for screening dopamine receptor affinity of drugs.

Authors:  P J Magistretti; M Schorderet
Journal:  Life Sci       Date:  1979-11-05       Impact factor: 5.037

6.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

7.  An isolated vascular tissue preparation showing a specific relaxant effect of dopamine [proceedings].

Authors:  R J Crooks; G R Martin
Journal:  Br J Pharmacol       Date:  1979-11       Impact factor: 8.739

8.  Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.

Authors:  I Creese; D R Burt; S H Snyder
Journal:  Life Sci       Date:  1975-09-15       Impact factor: 5.037

9.  Antagonism by droperidol of dopamine-induced relaxation in isolated dog arteries.

Authors:  N Toda; Y Hatano
Journal:  Eur J Pharmacol       Date:  1979-08-01       Impact factor: 4.432

10.  Dopamine-sensitive adenylate cyclase in the rat kidney particulate preparation.

Authors:  T Nakajima; F Naitoh; I Kuruma
Journal:  Eur J Pharmacol       Date:  1977-01-21       Impact factor: 4.432

View more
  6 in total

1.  Demonstration of vascular dopamine receptors in membranes from rabbit renal artery using 3H-spiroperidol binding.

Authors:  O E Brodde
Journal:  Experientia       Date:  1981-10-15

2.  Neurochemical profile of EMD 45609 (carmoxirole), a dopamine DA2-receptor agonist.

Authors:  A F Haase; H E Greiner; C A Seyfried
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-06       Impact factor: 3.000

3.  Demonstration of specific vascular dopamine receptors mediating vasodilation on the isolated rabbit mesenteric artery.

Authors:  O E Brodde; F J Meyer; W Schemuth; J Freistühler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-02       Impact factor: 3.000

4.  Dopamine inhibits prostaglandin F2 alpha-induced depolarization of rabbit jejunal arteries via activation of DA1-receptors.

Authors:  P Illes; W Nörenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

5.  Radioligand binding and autoradiographic analysis of dopamine receptors in the human heart.

Authors:  F Amenta; P Gallo; A Rossodivita; A Ricci
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

6.  Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum.

Authors:  C Semeraro; R Ferrini; L Allievi; F Pocchiari; S Nicosia; C Casagrande
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-11       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.